MENU
COO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

COO stock forecast, quote, news & analysis

CooperCompanies is one of the largest eyecare companies in the US... Show more

COO
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for COO with price predictions
Sep 11, 2026

COO's RSI Oscillator stays in oversold zone for 3 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.96% 3-day Advance, the price is estimated to grow further. Considering data from situations where COO advanced for three days, in 153 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.

COO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 124 of 213 cases where COO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 58%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 24, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on COO as a result. In 56 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.

The Moving Average Convergence Divergence Histogram (MACD) for COO turned negative on August 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 25 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.

COO moved below its 50-day moving average on August 27, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for COO crossed bearishly below the 50-day moving average on September 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.230) is normal, around the industry mean (4.965). P/E Ratio (18.517) is within average values for comparable stocks, (142.488). Projected Growth (PEG Ratio) (0.507) is also within normal values, averaging (3.236). Dividend Yield (0.000) settles around the average of (0.015) among similar stocks. P/S Ratio (2.492) is also within normal values, averaging (74.759).

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. COO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 89 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

A.I.Advisor
published Dividends

COO paid dividends on August 11, 2023

Cooper Companies (The) COO Stock Dividends
А dividend of $0.03 per share was paid with a record date of August 11, 2023, and an ex-dividend date of July 26, 2023. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 8.43B. The market cap for tickers in the group ranges from 126 to 130.41B. ISRG holds the highest valuation in this group at 130.41B. The lowest valued company is HGYMF at 126.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was -4%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 13%. NEPH experienced the highest price growth at 10%, while COO experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was 19%. For the same stocks of the Industry, the average monthly volume growth was -12% and the average quarterly volume growth was -35%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 60
Price Growth Rating: 54
SMR Rating: 81
Profit Risk Rating: 95
Seasonality Score: -49 (-100 ... +100)
View a ticker or compare two or three
COO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a maker of medical devices

Industry PharmaceuticalsOther

Profile
Details
Industry
Medical Specialties
Address
6101 Bollinger Canyon Road
Phone
+1 925 460-3600
Employees
15000
Web
https://www.coopercos.com
COO's RSI Oscillator stays in oversold zone for 3 days